Pediatric psoriasis affects approximately 1% of children in the U.S. For some kids, it’s a minor inconvenience characterized by a few itchy patches that respond well to treatment. For others, it’s a devastating disease that causes social anxiety, immense psychological distress and a reduced quality of life.
Understanding pediatric psoriasis
Pediatric psoriasis is a non-contagious, long-lasting (chronic) condition that causes skin cells to build up, creating itchy, red, raised areas and scales. It can be mild, moderate or severe and may appear anywhere on the body.
The disease tends to develop due to genetic factors or following a bacterial infection, such as strep throat. It can improve and worsen, seemingly at random, and although there is no cure for psoriasis, there are treatments available that can effectively manage the symptoms.
Types of Pediatric Psoriasis
There are seven types of psoriasis, but children are most likely to get one of two forms: plaque and guttate:
This is the most common form of pediatric psoriasis. It’s characterized by the development of itchy, painful red, dry patches or silvery scales. Common locations include the knees, lower back, elbows and scalp.
Typically triggered by a strep infection, guttate psoriasis causes small red dots to form throughout the body. When children are affected by this condition, they often go on to develop plaque psoriasis as well.
Current Treatment Options
In children, physicians typically recommend an antihistamine to help with the itching associated with psoriasis. You will also be advised to keep the area moisturized with a petroleum jelly.
If your child is over six-years-old, salicylic acid may be prescribed to help manage thick plaques.
Current treatment approaches are effective for mild pediatric psoriasis. They include corticosteroids, coal tar, anthralin and calcipotriene.
When psoriasis covers most of the body, light therapy is often recommended as a second-line treatment approach.
For particularly severe cases of pediatric psoriasis, your physician may prescribe oral medication if all other approaches have failed to effectively manage the condition.
Study: Exploring a new treatment approach for pediatric psoriasis
At Unison, we are actively recruiting qualified participants for a study evaluating the efficacy of a new treatment for pediatric psoriasis. If you are interested and available, and your child meets the qualifications outlined below, please contact us today.
- Length of trial: 2 months
- Age range: Healthy children 2 to 11 years of age
- Treatment: The efficacy of a new topical lotion/foam for managing the symptoms of pediatric psoriasis.
All of our clinical trials are free of cost. No medical insurance is necessary and you may be compensated for your participation.
Join our patient database
At Unison, we are committed to continually raising the bar for our patients. As such, we routinely hold clinical trials to test the safety and efficacy of new treatments, medications and drugs. If you’re interested in participating in this study, please join our patient database today and we will be in touch if you qualify.